Abstract
Atrial fibrillation (AF), the most common arrhythmia, is associated with an unfavorable prognosis.1,2 The majority of patients have AF in association with underlying (cardiac) diseases.3 In 15–30% of the patients, however, a known etiology is absent.4,5 This condition is called lone AF. Some of these patients have a positive family history for AF and may have a genetic cause or predisposition.6 Atrial fibrillation as an inherited disease was first reported in 1943.7 Darbar et al.8 observed that familial AF is more common than previously recognized. Of the 914 patients with AF, 36% had lone AF. A positive family history for AF was present in 15% of these lone AF patients (5% of all AF patients).8,9
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98:946–952.
Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695–703.
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257–e354.
Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993;341:1317–1322.
Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study. The College of French Cardiologists. Circulation 1999;99:3028–3035.
Fox CS, Parise H, D’Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291:2851–2855.
Wolf L. Familial auricular atrial fibrillation. N Engl J Med 1943;229:396–397.
Darbar D, Herron KJ, Ballew JD, et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 2003;41:2185–2192.
Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669–674.
Bowles KR, Gajarski R, Porter P, etal. Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 1996;98:1355–1360.
Bowles KR, Abraham SE, Brugada R, et al. Construction of a high-resolution physical map of the chromosome 10q22-q23 dilated cardiomyopathy locus and analysis of candidate genes. Genomics 2000;67:109–127.
Sebillon P, Bouchier C, Bidot LD, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 2003;40:560–567.
Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447–454.
Gruver EJ, Fatkin D, Dodds GA, et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 1999;83:13H–18H.
Ohkubo R, Nakagawa M, Higuchi I, et al. Familial skeletal myopathy with atrioventricular block. Intern Med 1999;38:856–860.
Sakata K, Shimizu M, Ino H, et al. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation 2005;111:3352–3358.
Schott JJ, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995;57:1114–1122.
Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421:634–639.
Hong K, Piper DR, az-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005;68:433–440.
Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 2005;16:394–396.
Giustetto C, Di MF, Wolpert C, et al. Short QT syndrome: Clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006;27:2440–2447.
Morita H, Kusano-Fukushima K, Nagase S, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002;40:1437–1444.
Gillmore JD, Booth DR, Pepys MB, Hawkins PN. Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart 1999;82:e2.
Gutierrez-Roelens I, Roy LD, Ovaert C, et al. A novel CSX/NKX2-5 mutation causes autosomaldominant AV block: Are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet 2006;14 (12):1313–1316.
Gollob MH, Seger JJ, Gollob TN, et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001;104:3030–3033.
Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Van Den Berg MP, Crijns HJ. Electrical and structural remodeling: Role in the genesis and maintenance of atrial fibrillation. Prog Cardiovasc Dis 2005;48:153–168.
Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905–911.
McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110:2163–2167.
Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003;107:2880–2883.
Sylvius N, Tesson F, Gayet C, et al. A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16. Am J Hum Genet 2001;68:241–246.
Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gainof-function mutation in familial atrial fibrillation. Science 2003;299:251–254.
Grunnet M, Jespersen T, Rasmussen HB, et al. KCNE4 is an inhibitory subunit to the KCNQ1 channel. J Physiol 2002;542:1 19–130.
Angelo K, Jespersen T, Grunnet M, Nielsen MS, Klaerke DA, Olesen SP. KCNE5 induces time-and voltage-dependent modulation of the KCNQ1 current. Biophys J 2002;83:1997–2006.
Ellinor PT, Moore RK, Patton KK, Ruskin JN, Pollak MR, MacRae CA. Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart 2004;90:1487–1488.
Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899–905.
Jiang M, Zhang M, Tang DG, et al. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation 2004;109:1783–1788.
Oberti C, Wang L, Li L, et al. Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy. Circulation 2004;1 10:3753–3759.
Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gainof-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005;332:1012–1019.
Ellinor PT, Petrov-Kondratov VI, Zakharova E, Nam EG, MacRae CA. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet 2006;7:70.
Olson TM, Alekseev AE, Liu XK, et al. Kv1.5 chan-nelopathy due to KCNA5 loss-of-function mutation causes atrial fibrillation. Hum Mol Genet 2006;15:2185–2191.
Laitinen-Forsblom PJ, Makynen P, Makynen H, et al. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias. J Cardiovasc Electrophysiol 2006;17:480–485.
Groenewegen WA, Firouzi M, Bezzina CR, et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003;92:14–22.
Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006;354:2677–2688.
Lai LP, Su MJ, Yeh HM, et al. Association of the human minK gene 38G allele with atrial fibrillation: Evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002;144:485–490.
Ehrlich JR, Zicha S, Coutu P, Hebert TE, Nattel S. Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. Cardiovasc Res 2005;67:520–528.
Fatini C, Sticchi E, Genuardi M, et al. Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J 2006;27:1712–1718.
Firouzi M, Ramanna H, Kok B, et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004;95:e29–e33.
Yamashita T, Hayami N, Ajiki K, et al. Is ACE gene polymorphism associated with lone atrial fibrillation? J pn Heart J 1997;38:637–641.
Tsai CT, Lai LP, Lin JL, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circula tion 2004;109:1640–1646.
Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study. Circulation 2002;106:331–336.
Schreieck J, Dostal S, von BN, et al. C825T polymor phism of the G-protein beta3 subunit gene and atrial fibrillation: Association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J 2004;148:545–550.
Ravn LS, Hofman-Bang J, Dixen U, et al. Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation. Am J Cardiol 2005;96:405–
Gaudino M, Andreotti F, Zamparelli R, et al. The-174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003;108 (Suppl. 1):II195–199.
Effendy FN, Bolognesi R, Bianchi G, Visioli O. Alternation of partial and total atrial standstill. J Electrocardiol 1979;12:121–127.
Talwar KK, Dev V, Chopra P, Dave TH, Radhakrishnan S. Persistent atrial standstillclinical, electrophysiological, and morphological study. Pacing Clin Electrophysiol 1991;14:1274–1280.
Ruff P, Leier CV, Schaal SF. Temporary atrial standstill. Am Heart J 1979;98:413–420.
Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: A long-term longitudinal study. Stroke 2003;34:901–908.
Liu YB, Chen WJ, Lee YT. Atrial standstill in a case of Kugelberg-Welander syndrome with cardiac involvement: An electrophysiologic study. Int J Cardiol 1999;70:207–210.
Fazelifar AF, Arya A, Haghjoo M, Sadr-Ameli MA. Familial atrial standstill in association with dilated cardiomyopathy. Pacing Clin Electrophysiol 2005;28:1005–1008.
Pierard LA, Henrard L, Demoulin JC. Persistent atrial standstill in familial Ebstein’s anomaly. Br Heart J 1985;53:594–597.
Carballal J, Asensio E, Hernandez R, et al. Ebstein’s anomaly, atrial paralysis and atrio-ventricular block: An uncommon association. Europace 2002;4:451–454.
Takehara N, Makita N, Kawabe J, et al. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 2004;255:137–142.
Harrison WH Jr, Derrick JR. Atrial standstill: A review, and presentation of two new cases of familial and unusual nature with reference to epicardial pacing in one. Angiology 1969;20:610–617.
Ward DE, Ho SY, Shinebourne EA. Familial atrial standstill and inexcitability in childhood. Am J Cardiol 1984;53:965–967.
Shah MK, Subramanyan R, Tharakan J, Venkitach-alam CG, Balakrishnan KG. Familial total atrial standstill. Am Heart J 1992;123:1379–1382.
Balaji S, Till J, Shinebourne EA. Familial atrial standstill with coexistent atrial flutter. Pacing Clin Electrophysiol 1998;21:1841–1842.
Disertori M, Guarnerio M, Vergara G, et al. Familial endemic persistent atrial standstill in a small mountain community: Review of eight cases. Eur Heart J 1983;4:354–361.
Makita N, Sasaki K, Groenewegen WA, et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2005;2:1128–1134.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Schoonderwoerd, B.A., van Tintelen, J.P., Wiesfeld, A.C., van Gelder, s.C. (2008). Familial Atrial Fibrillation and Standstill. In: Gussak, I., Antzelevitch, C., Wilde, A.A.M., Friedman, P.A., Ackerman, M.J., Shen, WK. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-84628-854-8_40
Download citation
DOI: https://doi.org/10.1007/978-1-84628-854-8_40
Publisher Name: Springer, London
Print ISBN: 978-1-84628-853-1
Online ISBN: 978-1-84628-854-8
eBook Packages: MedicineMedicine (R0)